News
-
-
COMMUNIQUÉ DE PRESSE
Harris Data Integrity Solutions Taps Julie Pursley as Director of Industry Relations
Harris Data Integrity Solutions appoints Julie Pursley as director of industry relations. Pursley to focus on team and client success, operational efficiencies, and thought leadership in health information management -
COMMUNIQUÉ DE PRESSE
Phase 2 Study Initiated to Evaluate Jaguar Health's Crofelemer for Microvillus Inclusion Disease (MVID), an Ultrarare Congenital Diarrheal Disorder
Jaguar Health, Inc. initiates Phase 2 study for crofelemer, a novel plant-based drug, in pediatric MVID patients. Study aims to evaluate drug efficacy for rare diseases MVID and SBS-IF -
-
-
COMMUNIQUÉ DE PRESSE
Electrovaya Inc. Closes US$11.1 Million Public Offering of Common Shares
Electrovaya Inc. successfully closes public offering of 5,175,000 Common Shares at US$2.15 per share, grossing US$11.1 million. Proceeds to be used for loan conditions, working capital, refinancing, and manufacturing facility purchase -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: AMAG Austria Metall AG: AMAG Austria Metall AG: Impairment requirement affects EBIT in FY 2024; EBITDA range remains unchanged
AMAG Austria Metall AG expects EBIT reduction in FY 2024 due to impairment charges while EBITDA range remains unchanged. Details on impairment impact and future profitability -
COMMUNIQUÉ DE PRESSE
Verisante Technology, Inc. Announces RTO Update:
SunRegen Healthcare AG closes $2.1 million private placement, advancing towards RTO with Verisante. SunRegen focuses on developing neurodegenerative drugs, starting with compound SBC003. Verisante to acquire 100% interest in SunRegen, aiming to qualify as Tier 2 Life Sciences Issuer
